COYA — Coya Therapeutics, Inc. catalysts
Next verified catalyst
2027-01-01 — Study of COYA 302 for the Treatment of ALS · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-01 (month) in 3mo
ESTIMATED |
READOUT
Study of COYA 302 for the Treatment of ALS
Phase 2/3 · Amyotrophic Lateral Sclerosis (ALS) |
COYA Coya Therapeutics, Inc. | COYA 302 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|